• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[急性肾损伤患者出现达比加群过量:手术时进行血液透析]

[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].

作者信息

Bachellerie B, Ruiz S, Conil J-M, Crognier L, Seguin T, Georges B, Fourcade O

机构信息

Pôle d'anesthésie réanimation, hôpital de Rangueil, 31059 Toulouse cedex 9, France.

Pôle d'anesthésie réanimation, hôpital de Rangueil, 31059 Toulouse cedex 9, France.

出版信息

Ann Fr Anesth Reanim. 2014 Jan;33(1):44-6. doi: 10.1016/j.annfar.2013.11.011. Epub 2013 Dec 28.

DOI:10.1016/j.annfar.2013.11.011
PMID:24378048
Abstract

Dabigatran is a direct thrombin inhibitor indicated for stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation. No reversal agent exists, but hemodialysis has been proposed as dabigatran removal method. We report a case of an 80-year-old man presenting hemorrhage with dabigatran overdose caused by obstructive acute renal failure. Before nephrostomy, several hemodialysis sessions were necessary to remove dabigatran probably because of its large volume of distribution.

摘要

达比加群是一种直接凝血酶抑制剂,适用于非瓣膜性心房颤动患者预防中风和全身性栓塞。目前尚无逆转剂,但血液透析已被提议作为去除达比加群的方法。我们报告一例80岁男性因梗阻性急性肾衰竭导致达比加群过量而出现出血的病例。在进行肾造瘘术前,可能由于达比加群分布容积较大,需要进行多次血液透析以清除达比加群。

相似文献

1
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].[急性肾损伤患者出现达比加群过量:手术时进行血液透析]
Ann Fr Anesth Reanim. 2014 Jan;33(1):44-6. doi: 10.1016/j.annfar.2013.11.011. Epub 2013 Dec 28.
2
Removal of dabigatran by hemodialysis.血液透析清除达比加群。
Am J Kidney Dis. 2013 Mar;61(3):487-9. doi: 10.1053/j.ajkd.2012.08.047. Epub 2012 Dec 5.
3
A case of dabigatran-associated acute renal failure.一例达比加群相关的急性肾衰竭病例。
WMJ. 2013 Aug;112(4):173-5; quiz 176.
4
Dabigatran overdose secondary to acute kidney injury and amiodarone use.因急性肾损伤和使用胺碘酮导致达比加群过量。
N Z Med J. 2013 Mar 1;126(1370):110-2.
5
Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.达比加群酯过量致肺出血的血液透析治疗。
Am J Kidney Dis. 2013 Sep;62(3):591-4. doi: 10.1053/j.ajkd.2013.02.361. Epub 2013 Apr 16.
6
Dabigatran overdose: case report of laboratory coagulation parameters and hemodialysis of an 85-year-old man.达比加群过量:一名85岁男性实验室凝血参数及血液透析的病例报告
Blood Coagul Fibrinolysis. 2015 Mar;26(2):225-9. doi: 10.1097/MBC.0000000000000221.
7
[Hemodialysis to remove anticoagulant dabigatran during emergencies].[紧急情况下通过血液透析清除抗凝剂达比加群]
Medicina (B Aires). 2014;74(2):121-3.
8
Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.与华法林相比,在接受达比加群治疗的急诊科患者中的出血并发症。
Ann Emerg Med. 2013 Apr;61(4):475-9. doi: 10.1016/j.annemergmed.2013.02.008.
9
Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.达比加群致老年中度肾功能不全患者胃肠道出血
Ann Pharmacother. 2012 Apr;46(4):e10. doi: 10.1345/aph.1Q747. Epub 2012 Apr 10.
10
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.达比加群、利伐沙班和阿哌沙班治疗心房颤动的间接比较。
Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28.

引用本文的文献

1
Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data.不同抗凝策略下的急性肾损伤:一项使用真实世界数据的大规模药物流行病学研究
Cardiovasc Drugs Ther. 2025 Jun;39(3):563-572. doi: 10.1007/s10557-024-07558-0. Epub 2024 Feb 6.
2
Anticoagulant-Related Nephropathy.抗凝相关肾病。
J Am Soc Nephrol. 2018 Dec;29(12):2787-2793. doi: 10.1681/ASN.2018070741. Epub 2018 Nov 12.
3
Oral anticoagulants and risk of nephropathy.口服抗凝剂与肾病风险
Drug Saf. 2015 Jun;38(6):527-33. doi: 10.1007/s40264-015-0290-z.
4
Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit.在重症监护病房中,使用静脉-静脉血液透析滤过治疗达比加群过量。
Clin Kidney J. 2015 Apr;8(2):199-201. doi: 10.1093/ckj/sfv001. Epub 2015 Jan 24.
5
Enhanced elimination of dabigatran through extracorporeal methods.通过体外方法增强达比加群的清除率。
J Med Toxicol. 2015 Mar;11(1):85-95. doi: 10.1007/s13181-014-0448-6.